A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
|ClinicalTrials.gov Identifier: NCT00335205|
Recruitment Status : Unknown
Verified June 2006 by Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : June 9, 2006
Last Update Posted : June 9, 2006
|Condition or disease||Intervention/treatment||Phase|
|Bipolar Disorder Major Depressive Disorder||Drug: ropinirole||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression.|
|Study Start Date :||April 2003|
- Hamilton Depression Rating Scale Score
- Montgomery Asberg Depression Rating Scale Score
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00335205
|Contact: Ari A Gershon, MDemail@example.com|
|Jerusalem Mental Health Center||Active, not recruiting|
|Chaim Sheba Medical Center, Dept. of Psychiatry||Recruiting|
|Tel Hashomer, Israel, 52621|
|Contact: Ari A Gershon, MD +972-3-5349105 firstname.lastname@example.org|
|Principal Investigator:||Leon Grunhaus, MD||Jerusalem Mental Health Center|